#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS

13. 2. 2025 Source: Athero Review | 1/2025

SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic str…

13. 2. 2025 Source: Athero Review | 1/2025

The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus

13. 2. 2025 Source: Athero Review | 1/2025

Determination and current management options for statin intolerance

13. 2. 2025 Source: Athero Review | 1/2025

GLP-1 receptors agonization as an effective antiatherosclerotic strategy

13. 2. 2025 Source: Athero Review | 1/2025

Cardiovascular risk in obese individuals: how to keep it under control?

13. 2. 2025 Source: Athero Review | 1/2025

Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options

13. 2. 2025 Source: Athero Review | 1/2025

Possibilities of using telemedicine methods in the management of lipitension

13. 2. 2025 Source: Athero Review | 1/2025

Telemedicine in the management of lipitension – opportunities and barriers to its use in Slovakia from the patient's perspective: a questionnaire study

13. 2. 2025 Source: Athero Review | 1/2025

Dutch Lipid Clinic Network Score – an effective tool for the diagnosis of familial hypercholesterolemia

13. 2. 2025 Source: Athero Review | 1/2025

Research on remarkable articles from international literature

13. 2. 2025 Source: Athero Review | 1/2025

28th Congress on Atherosclerosis: What did 2024 bring to dyslipidemia treatment?

13. 2. 2025 Source: Athero Review | 1/2025
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#